PJ, July 2011

How minoxidil was transformed from an antihypertensive to hair-loss drug

When patients taking the antihypertensive agent minoxidil in clinical trials in the late 1960s started getting a bit hairy, executives at Upjohn — the US pharmaceutical company that made the drug — dismissed it as a harmless side effect.…

New RPS must remember its roots and history if it is to lead effectively

The RPS must remember its roots and stand up and be counted if it is to attract and retain enough pharmacists to confer a representative mandate.…

Think long and hard about voting “no” in ballot

From Mr D. Tyas, MRPharmSElsewhere in this issue (p55), I attempt to discuss the professional representation of pharmacists by the Royal Pharmaceutical Society, past, present and future. During the course of debate in the Society’s “General group” virtual network forum on the present ballot on…

Can a partnership programme of support help to empower pharmacists to initiate or increase the number of patient medicines use reviews?

This paper aims to educate, motivate and support community pharmacists to increase the number of asthma medicines use reviews (MURs).…